Search

everythinglearnresearchcommunity

for

Search:↓

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

Non-laser devices show promise in treating hair issues, but more research is needed.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Bimatoprost effectively improves eyelashes in chemotherapy patients.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Scalp cooling effectively reduces hair loss from chemotherapy.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Microneedles show promise for cancer diagnosis and treatment due to their minimally invasive nature and effective drug delivery.

Low-dose oral minoxidil might help with hair loss during chemotherapy, but more research is needed.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.